Skip to main content
. 2012 Jan 3;30(8):863–870. doi: 10.1200/JCO.2011.35.6345

Fig 4.

Fig 4.

Response of an ROS1-positive patient with advanced non–small-cell lung cancer to crizotinib. Computed tomography scans of the chest were obtained (A and C) at baseline and (B and D) after 12 weeks of crizotinib. Shown are (A and B) coronal reconstructions and (C and D) axial slices.